Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

19 July 2020: Database Analysis

Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells

Chuan Hu 1ABCEF , Yuanhe Wang 1ABC , Chuan Liu 2DEF , Rui Shen 1DE , Bo Chen 3F , Kang Sun 1B , Huili Rao 4C , Lin Ye 3E , Jianjun Ye 3C , Shaoqi Tian 1ABCDEF*

DOI: 10.12659/MSM.924126

Med Sci Monit 2020; 26:e924126

Figure 5 The nomograms and corresponding results showed the prognostic value of AS events and clinicopathologic data. (A) Nomogram for predicting DFS in the SARC cohort. (B) Time-dependent ROC curves for 3- (red), 5- (green), and 7- (blue) year DFS. (C) Calibration plot of the AS-clinicopathologic nomogram in terms of the agreement between nomogram-predicted and observed 3- (red), 5- (green), and 7- (blue) year DFS in the SARC cohort. (D) Decision curve analysis of the AS-clinicopathologic nomogram for 3- (red), 5- (green), and 7- (blue) year risk in the SARC cohort. AS – alternative splicing; DFS – disease-free survival; SARC – sarcoma; ROC – receiver operating characteristic.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750